Article
Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.
Influenza and other respiratory viruses - 1 Jul 2010
Couturier Brianne A, Bender Jeffrey M, Schwarz Monica A, Pavia Andrew T, Hanson Kimberly E, She Rosemary C
Abstract excerpt
BACKGROUND: First-line treatment of influenza A 2009 H1N1 relies on neuraminidase inhibitors such as oseltamivir. Resistance conferred by the H275Y neuraminidase gene mutation is concerning and likely to increase. OBJECTIVES: To characterize oseltamivir resistance in a hospital-based patient population. PATIENTS AND METHODS: All available respiratory specimens positive for influenza A by direct fluorescent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
